Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations
Public ClinicalTrials.gov record NCT04191577. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 2 study, randomized, double-blind, placebo-controlled, multicenter study of oral CVN424 at two dose levels (low-dose and high-dose) in Parkinson's disease (PD) patients with motor fluctuations.
Study identification
- NCT ID
- NCT04191577
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 136 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 1, 2019
- Primary completion
- Nov 5, 2021
- Completion
- Dec 12, 2021
- Last update posted
- Jul 2, 2024
2019 – 2021
United States locations
- U.S. sites
- 21
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Collaborative Neuroscience Network, LLC | Long Beach | California | 90806 | — |
| SC3 Research - Pasadena | Pasadena | California | 91105 | — |
| Parkinson's Disease and Movement Disorders Center of Boca Raton | Boca Raton | Florida | 33486 | — |
| Nova Clinical Research | Bradenton | Florida | 34209 | — |
| Premier Clinical Research Institute | Miami | Florida | 33122 | — |
| Parkinson's Disease Treatment Center of SW Florida | Port Charlotte | Florida | 33980 | — |
| Accel Research Site - Brain and Spine Institute of Port Orange | Port Orange | Florida | 32127 | — |
| USF Parkinson's Disease and Movement Disorders Center | Tampa | Florida | 33613 | — |
| Charter Research | Winter Park | Florida | 32792 | — |
| NeuroTrials Research, Inc. | Atlanta | Georgia | 30328 | — |
| Parkinson's Disease and Movement Disorder Center | Kansas City | Kansas | 66160 | — |
| Boston Clinical Trials | Roslindale | Massachusetts | 02131 | — |
| Quest Research Institute | Farmington Hills | Michigan | 48334 | — |
| Bio Behavioral Health | Toms River | New Jersey | 08755 | — |
| New York Neurology Associates | New York | New York | 10003 | — |
| M3 Wake Research | Raleigh | North Carolina | 27612 | — |
| Optimed Research Ltd | Columbus | Ohio | 43235 | — |
| Neurology Diagnostics Inc | Dayton | Ohio | 45459 | — |
| Prisma Health | Greenville | South Carolina | 29615 | — |
| Central Texas Neurology Consultants | Round Rock | Texas | 78681 | — |
| Inland Northwest Research, LLC | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04191577, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2024 · Synced Sep 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04191577 live on ClinicalTrials.gov.